LBRX Earnings & Financial Statements
LB Pharmaceuticals Inc Common Stock
$37.69
+$3.08(+8.90%)
31
Overall
--
Value
27
Tech
36
Quality
Market Cap
$1.12B
Volume
399.81K
52W Range
$14.32 - $50.16
Target Price
$56.40
LBRX earnings and financial statements: LB Pharmaceuticals Inc Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.
LBRX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$30.40M | -$64.83M | -$18.84M |
| EBITDA | -$24.88M | -$61.15M | -$29.65M |
| Net income | -$25.20M | -$61.21M | -$38.79M |
| EPS (diluted) | $-3.13 | $-176.15 | $-21.86 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $312.93M | $33.53M | $45.66M |
| Total liabilities | $11.62M | $13.83M | $4.16M |
| Shareholders’ equity | $301.31M | $19.70M | $41.49M |
| Cash and equivalents | $250.17M | $22.98M | $14.98M |
| Long-term debt | $2.84M | $3.22M | - |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$35.20M | -$53.05M | -$12.09M |
| Capital expenditure | -$52.0K | - | - |
| Free cash flow | -$35.25M | -$53.82M | -$12.12M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LBRX | $37.69 | +8.9% | 399.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get LB Pharmaceuticals Inc Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW